Yan Shunchao相关文献与解析，生知库 | 链接生命科学的每一步

Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application

靶向启动因子以激活铁死亡和铜死亡用于乳腺癌治疗：进展及临床应用前景

期刊:Frontiers in Pharmacology

影响因子:4.8

doi:10.3389/fphar.2024.1493188

Imam, Murshid; Ji, Jiale; Zhang, Zhijie; Yan, Shunchao

Comparative analysis of human and mouse transcriptomes during skin wound healing

人类和小鼠皮肤伤口愈合过程中转录组的比较分析

期刊:Frontiers in Cell and Developmental Biology

影响因子:4.3

doi:10.3389/fcell.2024.1486493

Wang, Maochun; Zhang, Jiao; Qiao, Chongxu; Yan, Shunchao; Wu, Guoping

发表日期：2024

文献求助收藏

Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer

G蛋白偶联雌激素受体在三阴性乳腺癌中的最新进展和前景

期刊:Frontiers in Cell and Developmental Biology

影响因子:4.3

doi:10.3389/fcell.2024.1338448

Zhang, Duo; Chen, Hong; Wang, Jinpeng; Ji, Jiale; Imam, Murshid; Zhang, Zhijie; Yan, Shunchao

Identification of the miRNA-mRNA regulatory network in a mouse model of early fracture

在小鼠早期骨折模型中鉴定 miRNA-mRNA 调控网络

期刊:Frontiers in Genetics

影响因子:2.8

doi:10.3389/fgene.2024.1408404

Wang, Maochun; Xie, Zhiyang; Yan, Kaili; Qiao, Chongxu; Yan, Shunchao; Wu, Guoping

Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ: Retrospective cohort study

乳房切除术后激素受体阳性乳腺导管原位癌患者内分泌治疗的疗效和安全性：回顾性队列研究

期刊:Elife

影响因子:6.4

doi:10.7554/eLife.83045

Niu, Nan; Zhang, Yinan; Bai, Yang; Wang, Xin; Yan, Shunchao; Song, Dong; Xu, Hong; Liu, Tong; Hua, Bin; Zhang, Yingchao; Liu, Jinchi; Qiao, Xinbo; Liu, Jiaxiang; Zheng, Xinyu; Cao, Hongyi; Liu, Caigang

Divergent features of ERβ isoforms in triple negative breast cancer: progress and implications for further research

三阴性乳腺癌中ERβ亚型的差异特征：研究进展及对未来研究的启示

期刊:Frontiers in Cell and Developmental Biology

影响因子:4.3

doi:10.3389/fcell.2023.1240386

Yan, Shunchao; Wang, Jinpeng; Chen, Hong; Zhang, Duo; Imam, Murshid

Progress and prospects in research and clinical practice of hormone receptor-positive, HER-2-negative breast cancer with BRCA1/2 mutations

BRCA1/2突变型激素受体阳性、HER-2阴性乳腺癌的研究和临床实践进展与展望

期刊:Discover Oncology

影响因子:2.9

doi:10.1007/s12672-023-00732-0

Yan, Shunchao; Imam, Murshid

Estrogen Receptor Beta 1: A Potential Therapeutic Target for Female Triple Negative Breast Cancer.

雌激素受体β1：女性三阴性乳腺癌的潜在治疗靶点

期刊:Endocrinology

影响因子:3.3

doi:10.1210/endocr/bqac172

Dey Parama, Wang Alexander, Ziegler Yvonne, Kumar Sandeep, Yan Shunchao, Kim Sung Hoon, Katzenellenbogen John A, Katzenellenbogen Benita S

The predictive ability of plasma ESR1 mutations for the efficacy of endocrine therapy in hormone-receptor-positive advanced breast cancer

血浆ESR1突变对激素受体阳性晚期乳腺癌内分泌治疗疗效的预测能力

期刊:Oncotargets and Therapy

影响因子:2.8

doi:10.2147/OTT.S171465

Du, Yangfan; Li, Na; Jiao, Xin; Li, Kai; Yan, Shunchao

Transcriptomic analysis of bone transport reveals different functions between both ends

骨运输的转录组分析揭示了两端不同的功能

Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application

靶向启动因子以激活铁死亡和铜死亡用于乳腺癌治疗：进展及临床应用前景

Comparative analysis of human and mouse transcriptomes during skin wound healing

人类和小鼠皮肤伤口愈合过程中转录组的比较分析

Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer

G蛋白偶联雌激素受体在三阴性乳腺癌中的最新进展和前景

Identification of the miRNA-mRNA regulatory network in a mouse model of early fracture

在小鼠早期骨折模型中鉴定 miRNA-mRNA 调控网络

Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ: Retrospective cohort study

乳房切除术后激素受体阳性乳腺导管原位癌患者内分泌治疗的疗效和安全性：回顾性队列研究

Divergent features of ERβ isoforms in triple negative breast cancer: progress and implications for further research

三阴性乳腺癌中ERβ亚型的差异特征：研究进展及对未来研究的启示

Progress and prospects in research and clinical practice of hormone receptor-positive, HER-2-negative breast cancer with BRCA1/2 mutations

BRCA1/2突变型激素受体阳性、HER-2阴性乳腺癌的研究和临床实践进展与展望

Estrogen Receptor Beta 1: A Potential Therapeutic Target for Female Triple Negative Breast Cancer.

雌激素受体β1：女性三阴性乳腺癌的潜在治疗靶点

The predictive ability of plasma ESR1 mutations for the efficacy of endocrine therapy in hormone-receptor-positive advanced breast cancer

血浆ESR1突变对激素受体阳性晚期乳腺癌内分泌治疗疗效的预测能力